Dermatology
Multi-modal topical therapy providing swift relief from intense pruritus, erythema, and mixed bacterial-fungal cutaneous infections.
Clinical Overview & Pathophysiology
In this therapeutic area, Icon Drugs formulates high-stability compounds meeting pharmacopeial limits for content uniformity, dissolution rates, and organic impurities. Our manufacturing adheres to verified batch repeatability so prescribing clinicians can depend upon predictable bioavailability.
Physician & Institutional Inquiries
For complete bioequivalence dossiers, stability monographs, or hospital tender supply parameters in Dermatology, please contact our Medical Affairs or Business Enquiry team.
Indications & Conditions5 Addressed
- Mixed Fungal & Bacterial Dermatitis
- Eczema
- Psoriasis Flares
- Tinea Corporis & Pedis
- Severe Pruritus
Formulations in Dermatology
Active pharmaceutical formulations manufactured under WHO-GMP compliance